The scope of the report encompasses the major types of diagnostics technologies that have been used, the various industry structures such as the lab developed tests (LDTs) sector, and the major applications being commercialized and developed by a wide range of company types. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed.
Companies profiled in this report include: Abbott Diagnostics Inc., Advanced Cell Diagnostics Inc., Agendia Inc., Almac Group, Altheadx, Ameritox, Amgen Inc., Apocell Inc., Applied Biocode, Arrayit Corp., Arup Laboratories, Assurex Health, Astute Medical Inc., Asuragen Inc., Autogenomics Inc., Beckman Coulter Inc., Bio-Rad Inc., Biocartis Nv, Biocept Inc., Biodesix, Biomerieux, Biotheranostics Inc., Boreal Genomics, Cancer Genetics Inc., Cyprotex Plc, Dnavision, etc.
The global market for companion diagnostics reached nearly $4.4 billion in 2016. This market is expected to grow from nearly $5.5 billion in 2017 to $25.1 billion in 2022 at a compound annual growth rate (CAGR) of 35.5% for forecasted period 2017 to 2022.
BCC Research’s goal in conducting this study is to update the status of the companion diagnostics (CDx) market and assess its growth potential over the five-year period from 2017 to 2022. Particularly, focus was placed on further analysis of regulatory and market adoption dynamics, and disruptive technologies such as liquid biopsy. In addition, BCC Research was interested in updating the impact of CDx on different clinical sectors, not only cancer with respect to precision medicine but also pharmacogenomics and infectious disease, as well as emerging future applications including metabolic and liver disease, GI and inflammation, and CNS.
– An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
– Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
– Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
– Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. MarketInsightsReports is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resource, automobile, IT, technology and media, food and beverages, and consumer goods, among others.
Contact us: +1 (704) 266-3234 | email@example.com
Connect With us on: